BANT vs MEDDIC: count who must sign off, then pick one
Use BANT to screen fast on small, simple deals, and MEDDIC once several people have to agree and the deal will run for months. BANT asks the person you're talking to four questions (budget, authority, need, timing), while MEDDIC maps the whole deal, from the numbers that matter and who signs to how they decide, the pain and who is on your side. If you're unsure, start with BANT on the first call and move to MEDDIC when a second stakeholder appears.
Updated
How are BANT and MEDDIC different, side by side?
| BANT | MEDDIC | |
|---|---|---|
| Stands for | Budget, Authority, Need, Timing (some teams say Timeline) | Metrics, Economic buyer, Decision criteria, Decision process, Identify pain, Champion |
| Number of parts | 4 | 6 |
| What it tests | Whether this contact can and will buy | Whether you understand the buying process well enough to win it |
| Origin (vendor accounts) | Created at IBM in the 1950s, per Mindtickle | Developed at Parametric Technology Corporation (PTC) in the 1990s; Nutshell and Supernormal credit Jack Napoli and Dick Dunkel |
| Fits best | Short cycles, one or two people deciding, smaller deals | Longer cycles, several stakeholders, bigger or more custom deals |
| Training needed | Little. Four questions a new rep can ask on call one | More. Reps have to learn what each part looks like in a live deal |
| Where it breaks | A friendly contact can pass all four and still have no power over the budget | It's slow if you apply it to a deal that closes in a week |
The origin dates come from vendor blogs, not from the original authors, so treat them as the commonly told story.
What does each letter ask you to find out?
Here are the questions to bring to the call. They are our wording, not the official script of either framework.
| Part | The question to answer |
|---|---|
| Budget | Is money set aside, or can it be, for a problem this size? |
| Authority | Does this person sign, or just influence? |
| Need | What's broken, and what does it cost them today? |
| Timing | What date are they working toward, and why that date? |
| Metrics | Which number will they use to say this worked? |
| Economic buyer | Who can say yes without asking anyone else, and have you met them? |
| Decision criteria | How will they score the vendors on their shortlist? |
| Decision process | What are the steps from now to signature, and who is in each one? |
| Identify pain | What does it cost them to leave things as they are? |
| Champion | Who on their side is selling this internally while you're not around? |
Many teams add a second C for competition (MEDDICC) or a P for paper process (MEDDPICC), per Supernormal. Add them only after the base six are routine.
How do you decide which one to use?
Count the people who have to agree. That's our rule, not a study, and it works because the more people involved, the less one contact's answers tell you.
| Situation | Use |
|---|---|
| One person decides, deal closes in days or a few weeks | BANT |
| You're screening inbound leads or a cold-call list | BANT as a gate, then stop |
| Two or more people in different functions have to agree | MEDDIC |
| There is a security, legal or procurement step | MEDDIC (and consider the paper-process P) |
| You're a founder selling your first deals | BANT questions, plus "who else needs to say yes?" |
Buyer research backs the idea that more than one person is usually involved. Gartner's survey of 632 B2B buyers (fielded in 2024, released May 2025) found buying groups of 5 to 16 people, and its release reports that 74% of buyer teams showed unhealthy conflict during the decision and that teams reaching consensus were 2.5x more likely to report a high-quality deal. Small purchases involve fewer people, so check your own deals. For the numbers, see how many people are in a B2B buying committee.
What does the same deal look like scored both ways?
Here is an illustrative example (invented, not a real account). A VP of Operations at a 200-person company tells you on call one: "We have budget, I'm the one buying, and we want this live by the end of the quarter."
| BANT | Result | MEDDIC | Result |
|---|---|---|---|
| Budget | Yes, she says so | Metrics | Unknown. No number agreed |
| Authority | Yes, she says she's buying | Economic buyer | Unknown. A CFO sign-off may be needed |
| Need | Yes, a manual reporting problem | Decision criteria | Unknown. IT hasn't weighed in |
| Timing | Yes, end of quarter | Decision process | Unknown. Security review not discussed |
| Qualified | Identify pain | Partly. No cost attached yet | |
| Champion | Possibly her, untested |
BANT says go. MEDDIC says you know one answer in six. Both are right: the lead is worth a second call, and the deal is not yet forecastable. The fix is the next call's agenda: get the metric, ask who else has to approve, and ask her to introduce you to that person. For how to forecast with that in mind, see what a good win rate is and how much pipeline you need.
How do you run both without slowing down?
Let BANT decide whether a deal earns a second call, and let MEDDIC track everything after that.
- First call: ask the four BANT questions. If two or more are a clear no, stop. If it passes, book the next call.
- After call one: open a MEDDIC checklist in your CRM notes, one line per part, each marked known, partly known or unknown.
- Each call after that: pick the two unknowns that matter most and make them the agenda.
- Weekly review: any deal with three or more unknowns doesn't go in your commit forecast. See how pipeline coverage works.
For the questions to ask on a call, our cold call objection handling page covers "we already have a vendor" and "no budget", the two most common ways a BANT answer goes sour. When a deal that passed these checks still ends with nobody buying, see why B2B deals end in no decision. To learn from the deals you win and lose, see how to run a win-loss review.
When should you skip each framework?
- BANT: skip it as your only test on any deal with more than one decision maker. A contact can say yes to all four and still lack the power to buy.
- BANT: skip the "budget" question as a gate on a first cold call. Many buyers haven't set a budget for a problem they haven't named yet; ask about the cost of the problem instead.
- MEDDIC: skip it for a deal you expect to close in days. Six areas of homework cost more than the deal is worth.
- MEDDIC: skip the full version if you have no way to reach a second person in the account. Fix your access first; see how to find the decision maker.
- MEDDICC and MEDDPICC: skip the extra letters until your team can fill in the first six without prompts.
See also: What is a mutual action plan, and how do you get a buyer to agree to one?
Sources
Research and vendor pages accessed October 1, 2026.
- Mindtickle, The BANT sales framework: https://www.mindtickle.com/blog/what-is-bant-sales-framework/
- Nutshell, What is MEDDIC sales: https://www.nutshell.com/blog/meddic-sales-methodology
- Supernormal, MEDDIC, MEDDICC and MEDDPICC explained: https://www.supernormal.com/blog/medpicc
- Gartner press release, May 7, 2025, 74% of B2B buyer teams show unhealthy conflict: https://www.gartner.com/en/newsroom/press-releases/2025-05-07-gartner-sales-survey-finds-74-percent-of-b2b-buyer-teams-demonstrate-unhealthy-conflict-during-the-decision-process